Concentrated Exposure Therapy for Post-traumatic Stress Disorder - a Cohort Study
Study Details
Study Description
Brief Summary
Post-traumatic stress disorder (PTSD) is a prevalent and disabling condition. Trauma-focused psychotherapy, including cognitive behavioural therapy (CBT), are among the recommended first-line treatment alternatives. However, a substantial proportion of patients decline, drop-out or do not respond to current psychotherapies. Previous research suggests that intensive or concentrated formats of trauma-focused psychotherapy can lead to faster recover and lower attrition, but there are currently few studies of these approaches. The current study will investigate the acceptability. treatment satisfaction and preliminary changes in symptoms after four consecutive days of concentrated CBT for PTSD.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
The study will investigate the research questions in three stages. In the first stage four patients will be treated individually. In the second stage two groups of four patients will be treated, with at least a 1:1 ratio between therapists and patients per group. In the third stage 30 patients will be treated in groups of about four patients per group, with at least a 1:1 ratio between therapists and patients per group. The primary outcome measure is changes in PTSD-related symptoms as measured using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5). Acceptability will be measured as the proportion of patients accepting treatment when offered, while attrition is measured as the proportion of patients that withdraw from treatment after it has started. Several other measures will be collected to measure treatment satisfaction, related symptoms, and functional impairment.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Individual therapy over four consecutive days Treatment will be delivered individually over four consecutive days |
Behavioral: Concentrated cognitive behavioral therapy
A psychological intervention consisting of psychoeducation and exposure therapy with the goal of changing the tolerability and negative interpretations of post-traumatic symptoms. The treatment is tailored to the individual patient through all stages, including relapse prevention and planning how to use treatment principles in daily life
Other Names:
|
| Combined Individual and group therapy over four consecutive days Treatment will be delivered in a mix of individual and group sessions over four consecutive days |
Behavioral: Concentrated cognitive behavioral therapy
A psychological intervention consisting of psychoeducation and exposure therapy with the goal of changing the tolerability and negative interpretations of post-traumatic symptoms. The treatment is tailored to the individual patient through all stages, including relapse prevention and planning how to use treatment principles in daily life
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) [Change in scores from before treatment to one week after treatment]
Clinician-administered interview to diagnose and the severity of PTSD
- Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) [Change in scores from one week after treatment to three months after treatment]
Clinician-administered interview to diagnose and the severity of PTSD
- Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) [Change in scores from three months after treatment to twelve months after treatment]
Clinician-administered interview to diagnose and the severity of PTSD
Secondary Outcome Measures
- Client Satisfaction Questionnaire 8 (CSQ-8) [One week after treatment]
Patient-rated questionnaire of treatment satisfaction
- Client Satisfaction Questionnaire 8 (CSQ-8) [Three months after treatment]
Patient-rated questionnaire of treatment satisfaction
- Client Satisfaction Questionnaire 8 (CSQ-8) [Twelve months after treatment]
Patient-rated questionnaire of treatment satisfaction
Eligibility Criteria
Criteria
Inclusion Criteria:
-
fulfills DSM-5 criteria for PTSD
-
One or more single traumas in adolescence or adulthood
-
Speaks and writes Norwegian
Exclusion Criteria:
-
New or unstable psychopharmacological treatment within last four weeks
-
fulfills ICD-11 criteria for complex PTSD
-
Ongoing substance abuse
-
Ongoing danger of suicide
-
Ongoing borderline personality disorder
-
Ongoing psychosis
-
Intellectual disability
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Haukeland University Hospital | Bergen | Vestland | Norway | 5021 |
Sponsors and Collaborators
- Haukeland University Hospital
- University of Bergen
Investigators
- Principal Investigator: Anders L Thorsen, PhD, Haukeland University Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- B4DT-PTSD1